Tags » Johnson & Johnson

JNJ sales went up, net income $4,272M in Q3 2016

Johnson & Johnson has reported on Tuesday net earnings and diluted earnings per share for the third quarter of 2016 of$4.3 billion and $1.53, respectively. Third quarter 2015 net earnings included after-tax intangible amortization expense of approximately $0.4 billion and a charge for after-tax special items of approximately $0.4 billion. 223 more words


Why These Copycat Drugs Aren’t Slashing Best-Sellers’ Prices

Insurers and health care providers had hoped a new class of medicines called biosimilars would keep a check on high drug prices and reduce health spending in America. 508 more words


Today’s Top 7 Business News Headlines


  • Intel Q3 Earnings Up but Revenue Forecasts Fall
  • Goldman Sachs Q3 Earnings Up on Trading
  • Johnson & Johnson Revenue Up
  • Yahoo Core Q3 Revenue Falls Again…
  • 17 more words
Business Headlines

Johnson & Johnson Says Its Pharma Future Is Bright

Johnson & Johnson on Tuesday reported a better-than-expected quarterly profit and said its phamaceutical business will keep prospering despite the threatened launch of a competitor for its blockbuster Remicade arthritis drug. 356 more words


Is diabetes tech here to stay?

Photo (cc) Alan Levine

It seems to be a trend that all new biotech advancements cost more than their predecessors, which makes complete sense in some ways. 421 more words

Medical Advancements

Johnson & Johnson Warns Diabetics Of Potential Insulin Pump Hack

NEW YORK (CBSNewYork) — Johnson and Johnson says its OneTouch Insulin Pump has a big bug that makes it vulnerable to hackers.

According to cybersecurity Rapid7, Inc. 97 more words


Insulin pumps could be hacked warns Johnson & Johnson

(Reuters) – Johnson & Johnson is telling patients that it has learned of a security vulnerability in one of its insulin pumps that a hacker could exploit to overdose diabetic patients with insulin, though it describes the risk as low. 685 more words